Buy or Sell ? Support and Resistance
What is MACD and how to read it?
How RSI can help?
RSI : 000
0HOH.L Stock Summary
Top 10 Correlated ETFs
0HOH.L
In the News
0HOH.L Financial details
Company Rating
Neutral
Market Cap
221.65M
Income
-91.17M
Revenue
21.73M
Book val./share
2.04
Cash/share
1.68
Dividend
-
Dividend %
-
Employees
323
Optionable
No
Shortable
Yes
Earnings
07 May 2024
P/E
-1.66
Forward P/E
-
PEG
0.18
P/S
12.94
P/B
0.68
P/C
0.59
P/FCF
-1
Quick Ratio
1.24
Current Ratio
1.55
Debt / Equity
0.32
LT Debt / Equity
-
-
-
EPS (TTM)
-0.74
EPS next Y
-
EPS next Q
-
EPS this Y
-71.49%
EPS next Y
-
EPS next 5Y
-
EPS last 5Y
-20.51%
Revenue last 5Y
-41.95%
Revenue Q/Q
79.85%
EPS Q/Q
-1.49%
-
-
-
-
SMA20
-
SMA50
-
SMA100
-66.67%
Inst Own
-
Inst Trans
-
ROA
-15%
ROE
-34%
ROC
-0.3%
Gross Margin
-231%
Oper. Margin
-627%
Profit Margin
-420%
Payout
-
Shs Outstand
-
Shs Float
-
-
-
-
-
Target Price
-
52W Range
0.88565-5.528
52W High
-
52W Low
-
RSI
36
Rel Volume
0.16
Avg Volume
57.27K
Volume
9.13K
Perf Week
-16.3%
Perf Month
-35.44%
Perf Quarter
-65.47%
Perf Half Y
-64.34%
-
-
-
-
Beta
0.799
-
-
Volatility
0.08%, 0.15%
Prev Close
-1.23%
Price
0.9877
Change
-8.55%
0HOH.L Financial Performance
Yearly Fundamentals Overview
Last date of statement is 2022-12-31
Metric | History | 2018-12-31 | 2019-12-31 | 2020-12-31 | 2021-12-31 | 2022-12-31 |
---|---|---|---|---|---|---|
2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
Revenue per share | 1.05 | 0.81 | 0 | 0.05 | 0.05 | |
Net income per share | -10.68 | -14.31 | -9.95 | -11.89 | -3.39 | |
Operating cash flow per share | -7.95 | -10.23 | -7.56 | -9.22 | -4.49 | |
Free cash flow per share | -9.02 | -11.61 | -8.03 | -9.56 | -4.66 | |
Cash per share | 26.62 | 20.05 | 10.96 | 4.38 | 2.31 | |
Book value per share | 36.23 | 23.28 | 21.79 | 5.43 | 2.5 | |
Tangible book value per share | 35.72 | 22.79 | 21.63 | 5.35 | 2.36 | |
Share holders equity per share | 36.23 | 23.28 | 21.79 | 5.43 | 2.5 | |
Interest debt per share | 0 | 0.37 | 0.16 | 0.34 | 0.65 | |
Market cap | 393.36M | 417.24M | 470.07M | 520.96M | 534.22M | |
Enterprise value | -9.22M | 281.02M | 273.35M | 447.1M | 701.1M | |
P/E ratio | -0.71 | -0.53 | -0.76 | -0.64 | -2 | |
Price to sales ratio | 7.21 | 9.34 | 0 | 142.26 | 148.52 | |
POCF ratio | -0.95 | -0.74 | -1 | -0.82 | -1.51 | |
PFCF ratio | -0.84 | -0.65 | -0.94 | -0.79 | -1.46 | |
P/B Ratio | 0.21 | 0.32 | 0.35 | 1.39 | 2.72 | |
PTB ratio | 0.21 | 0.32 | 0.35 | 1.39 | 2.72 | |
EV to sales | -0.17 | 6.29 | 0 | 122.09 | 194.91 | |
Enterprise value over EBITDA | 0.02 | -0.35 | -0.49 | -0.8 | -1.85 | |
EV to operating cash flow | 0.02 | -0.5 | -0.58 | -0.7 | -1.99 | |
EV to free cash flow | 0.02 | -0.44 | -0.55 | -0.68 | -1.91 | |
Earnings yield | -1.41 | -1.89 | -1.32 | -1.57 | -0.5 | |
Free cash flow yield | -1.19 | -1.54 | -1.06 | -1.26 | -0.69 | |
Debt to equity | 0 | 0.02 | 0.01 | 0.06 | 0.26 | |
Debt to assets | 0 | 0.01 | 0.01 | 0.04 | 0.09 | |
Net debt to EBITDA | 0.73 | 0.17 | 0.36 | 0.13 | -0.44 | |
Current ratio | 9.69 | 5.15 | 5.97 | 2.2 | 1.56 | |
Interest coverage | 0 | 0 | 0 | 0 | 0 | |
Income quality | 0.74 | 0.71 | 0.84 | 1.13 | 1.32 | |
Dividend Yield | 0 | 0 | 0 | 0 | 0 | |
Payout ratio | 0 | 0 | 0 | 0 | 0 | |
Sales general and administrative to revenue | 0 | 0 | 0 | 0 | 0 | |
Research and developement to revenue | 8.22 | 12.65 | 0 | 85.88 | 65.54 | |
Intangibles to total assets | 0.01 | 0.02 | 0.01 | 0.01 | 0.02 | |
Capex to operating cash flow | 0.13 | 0.14 | 0.06 | 0.04 | 0.04 | |
Capex to revenue | -1.02 | -1.71 | 0 | -6.28 | -3.67 | |
Capex to depreciation | -3.25 | -4.37 | -5.15 | -4.22 | -2.64 | |
Stock based compensation to revenue | 2.03 | 2.93 | 0 | 26.96 | 9.78 | |
Graham number | 93.3 | 86.57 | 69.85 | 38.12 | 13.81 | |
ROIC | -0.3 | -0.55 | -0.39 | -1.21 | -0.8 | |
Return on tangible assets | -0.25 | -0.46 | -0.35 | -1.39 | -0.49 | |
Graham Net | 19.94 | 12.09 | 4.22 | 1.29 | -2.22 | |
Working capital | 1.27B | 928.59M | 1.01B | 183.53M | 71.25M | |
Tangible asset value | 1.86B | 1.26B | 1.35B | 368.63M | 185.83M | |
Net current asset value | 1.06B | 709.74M | 789.34M | 117M | -159.07M | |
Invested capital | 0 | 0.02 | 0.01 | 0.06 | 0.26 | |
Average receivables | 10.97M | 13.2M | 7.6M | 5.74M | 9.2M | |
Average payables | 15.35M | 30.41M | 28.4M | 19.85M | 25.49M | |
Average inventory | 0.5 | -6.41M | -1.06M | 5.35M | -4.64M | |
Days sales outstanding | 90.73 | 104.79 | 0 | 907.72 | 942.18 | |
Days payables outstanding | 14.48 | 768.82 | 896.02 | 234.39 | 607.41 | |
Days of inventory on hand | 0 | -229.35 | 694.06 | 0 | -224.77 | |
Receivables turnover | 4.02 | 3.48 | 0 | 0.4 | 0.39 | |
Payables turnover | 25.21 | 0.47 | 0.41 | 1.56 | 0.6 | |
Inventory turnover | 0 | -1.59 | 0.53 | 40.31M | -1.62 | |
ROE | -0.29 | -0.61 | -0.46 | -2.19 | -1.36 | |
Capex per share | -1.07 | -1.38 | -0.47 | -0.33 | -0.17 |
Quarterly Fundamentals Overview
Last date of statement is 2023-09-30 for Q3
Metric | History | 2022-09-30 | 2022-12-31 | 2023-03-31 | 2023-06-30 | 2023-09-30 |
---|---|---|---|---|---|---|
2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
Revenue per share | 0 | 0 | 0.02 | 0.06 | 0.11 | |
Net income per share | -0.94 | 0.38 | 0.21 | -0.67 | -0.66 | |
Operating cash flow per share | -0.94 | -0.66 | -0.84 | -0.67 | -0.57 | |
Free cash flow per share | -0.96 | -0.72 | -0.85 | -0.68 | -0.59 | |
Cash per share | 1.73 | 2.13 | 3.11 | 2.27 | 1.68 | |
Book value per share | 1.95 | 2.3 | 3.45 | 2.66 | 2.04 | |
Tangible book value per share | 1.88 | 2.18 | 3.34 | 2.56 | 1.94 | |
Share holders equity per share | 1.95 | 2.3 | 3.45 | 2.66 | 2.04 | |
Interest debt per share | 0.54 | 0.6 | 0.5 | 0.62 | 0.66 | |
Market cap | 514.94M | 579.07M | 324.97M | 359.75M | 328.38M | |
Enterprise value | 725.11M | 745.95M | 357.88M | 492.37M | 457.86M | |
P/E ratio | -1.68 | 4.49 | 3.82 | -1.23 | -1.14 | |
Price to sales ratio | 7.25K | 9.19K | 136.48 | 52.21 | 26.5 | |
POCF ratio | -6.69 | -10.29 | -3.75 | -4.95 | -5.31 | |
PFCF ratio | -6.58 | -9.43 | -3.7 | -4.9 | -5.14 | |
P/B Ratio | 3.24 | 2.95 | 0.92 | 1.24 | 1.48 | |
PTB ratio | 3.24 | 2.95 | 0.92 | 1.24 | 1.48 | |
EV to sales | 10.21K | 11.84K | 150.31 | 71.46 | 36.95 | |
Enterprise value over EBITDA | -8.52 | -9.91 | -4.29 | -5.84 | -5.47 | |
EV to operating cash flow | -9.41 | -13.26 | -4.13 | -6.77 | -7.4 | |
EV to free cash flow | -9.26 | -12.15 | -4.08 | -6.71 | -7.17 | |
Earnings yield | -0.15 | 0.06 | 0.07 | -0.2 | -0.22 | |
Free cash flow yield | -0.15 | -0.11 | -0.27 | -0.2 | -0.19 | |
Debt to equity | 0.28 | 0.26 | 0.14 | 0.23 | 0.32 | |
Debt to assets | 0.08 | 0.09 | 0.07 | 0.1 | 0.12 | |
Net debt to EBITDA | -2.47 | -2.22 | -0.39 | -1.57 | -1.55 | |
Current ratio | 1.27 | 1.56 | 3.03 | 2.13 | 1.55 | |
Interest coverage | 0 | 0 | 0 | 0 | 0 | |
Income quality | 1.01 | -1.75 | -4.08 | 1 | 0.86 | |
Dividend Yield | 0 | 0 | 0 | 0 | 0 | |
Payout ratio | 0 | 0.01 | 0 | -0.01 | 0 | |
Sales general and administrative to revenue | 0 | 0 | 0 | 0 | 0 | |
Research and developement to revenue | 729.04 | 708.63 | 19.38 | 6.14 | 3.67 | |
Intangibles to total assets | 0.01 | 0.02 | 0.02 | 0.02 | 0.02 | |
Capex to operating cash flow | 0.02 | 0.09 | 0.01 | 0.01 | 0.03 | |
Capex to revenue | -17.8 | -81.08 | -0.46 | -0.1 | -0.16 | |
Capex to depreciation | -0.91 | -4.07 | -1.02 | -0.73 | -1.9 | |
Stock based compensation to revenue | 129.75 | 74.27 | 2.26 | 0.84 | 0.39 | |
Graham number | 6.41 | 4.43 | 4 | 6.34 | 5.49 | |
ROIC | -0.2 | -0.16 | -0.13 | -0.14 | -0.16 | |
Return on tangible assets | -0.15 | 0.06 | 0.03 | -0.11 | -0.12 | |
Graham Net | -2.6 | -2.05 | -0.06 | -1.02 | -1.65 | |
Working capital | 33.71M | 71.25M | 235.14M | 152.96M | 88.12M | |
Tangible asset value | 153.21M | 185.83M | 343.48M | 277.88M | 211.52M | |
Net current asset value | -200.8M | -159.07M | 13.08M | -86.4M | -144M | |
Invested capital | 0.28 | 0.26 | 0.14 | 0.23 | 0.32 | |
Average receivables | 9.91M | 10.13M | 11.7M | 14.1M | 18.54M | |
Average payables | 21.74M | 21.86M | 22.16M | 15.06M | 15.37M | |
Average inventory | 1 | -4.64M | -2.74M | 8.73M | 17.31M | |
Days sales outstanding | 13.91K | 13.26K | 533.8 | 183.8 | 167.04 | |
Days payables outstanding | 1.21K | 1.77K | 512.78 | 102.52 | 163.09 | |
Days of inventory on hand | 0 | -654.39 | 101.54 | 128.38 | 172.27 | |
Receivables turnover | 0.01 | 0.01 | 0.17 | 0.49 | 0.54 | |
Payables turnover | 0.07 | 0.05 | 0.18 | 0.88 | 0.55 | |
Inventory turnover | 1.39M | -0.14 | 0.89 | 0.7 | 0.52 | |
ROE | -0.48 | 0.16 | 0.06 | -0.25 | -0.32 | |
Capex per share | -0.02 | -0.06 | -0.01 | -0.01 | -0.02 |
0HOH.L Frequently Asked Questions
What is bluebird bio, Inc. stock symbol ?
bluebird bio, Inc. is a US stock , located in Cambridge of Ma and trading under the symbol 0HOH.L
What is bluebird bio, Inc. stock quote today ?
bluebird bio, Inc. stock price is $0.9877 today.
Is bluebird bio, Inc. stock public?
Yes, bluebird bio, Inc. is a publicly traded company.